Toggle navigation
PDFSEARCH.IO
Document Search Engine - browse more than 18 million documents
Sign up
Sign in
Back to Results
First Page
Meta Content
View Document Preview and Link
ALLY Trial Demonstrates High Cure Rates for Investigational Daclatasvir and Sofosbuvir Combination among Genotype 3 Hepatitis C Patients Daclatasvir+sofosbuvir regimen achieves SVR12 in 90% of treatment-naïve and 86% of
Add to Reading List
Document Date: 2014-11-10 11:48:39
Open Document
File Size: 101,71 KB
Share Result on Facebook
UPDATE
ALLY Trial Demonstrates High Cure Rates for Investigational Daclatasvir and Sofosbuvir Combination among Genotype 3 Hepatitis C Patients Daclatasvir+sofosbuvir regimen achieves SVR12 in 90% of treatment-naïve and 86% of